Merkel cell carcinoma associated with tofacitinib therapy.

Wallis, Luke S; Rakita, Uros; Grushchak, Solomiya; Asadbeigi, Sepideh N; Yazdan, Pedram; Liu, Wenhua; Krunic, Aleksandar

Wallis, Luke S; Rakita, Uros; Grushchak, Solomiya; Asadbeigi, Sepideh N; Yazdan, Pedram; Liu, Wenhua; Krunic, Aleksandar.

Afiliación

Wallis LS; Department of Dermatology, Rush University Medical Center, Chicago, Illinois.
Rakita U; Chicago Medical School at Rosalind Franklin University, Chicago, Illinois.
Grushchak S; Department of Dermatology, Cook County Health and Hospitals System, Chicago, Illinois.
Asadbeigi SN; Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Yazdan P; Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Liu W; Consolidated Pathology Consultants, Libertyville, Illinois.
Krunic A; Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.

JAAD Case Rep ; 14: 94-96, 2021 Aug.

Article en En | MEDLINE | ID: mdl-34295956

Palabras clave

IFN, interferon; IL, interleukin; JAK, Janus-associated kinases; Janus kinase inhibitor; MCC, Merkel cell carcinoma; MCPyV, Merkel cell polyomavirus; Merkel cell carcinoma; STAT, signal transducer and activator of transcription; tofacitinib

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Tipo de estudio: Risk_factors_studies Idioma: En Revista: JAAD Case Rep Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Tipo de estudio: Risk_factors_studies Idioma: En Revista: JAAD Case Rep Año: 2021 Tipo del documento: Article